Trials / Completed
CompletedNCT00707538
A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
A Phase I Dosimetry, Biodistribution and Safety Study of BMS747158 in Healthy Subjects Undergoing 2-Day Rest/Stress Positron Emission Tomography
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Lantheus Medical Imaging · Industry
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical research study is to learn the biodistribution of injection of BMS747158 at stress and assess the safety of two doses of BMS747158
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS747158 | 2 IV injection of \~11 mCi (total) F-18 labeled compound |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2008-07-01
- Last updated
- 2020-11-10
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00707538. Inclusion in this directory is not an endorsement.